Fungal-Driven Airways Dis-Immunity From Asthma to Allergic Bronchopulmonary Aspergillosis: Dissecting Similarities

Marco Caminati1,2, Isabella Annesi-Maesano3,4,5, Wojciech Feleszko6

  • 1Allergy Unit and Asthma Center, Verona Integrated University Hospital, Verona, Italy.

Allergy
|August 2, 2025
PubMed

Insights

Severe asthma and allergic bronchopulmonary aspergillosis (ABPA) share similarities, complicating diagnosis. Recognizing severe asthma with fungal sensitization (SAFS) is crucial for better management and preventing irreversible damage.

Area of Science:

  • Pulmonology
  • Allergy and Immunology
  • Mycology

Background:

  • Severe asthma and allergic bronchopulmonary aspergillosis (ABPA) frequently coexist, presenting overlapping symptoms and pathobiological drivers.
  • Severe asthma with fungal sensitization (SAFS) further complicates accurate phenotyping, increasing disease burden and risk of irreversible lung damage.

Purpose of the Study:

  • To provide a comparative overview of recent advances in understanding asthma, ABPA, and SAFS.
  • To update the practical approach to diagnosing and managing these complex respiratory conditions.
  • To highlight the need for precise endotyping for targeted treatments and improved patient outcomes.

Main Methods:

  • Comparative review of pathophysiology, clinical manifestations, and biomarkers.
  • Analysis of current diagnostic challenges and management strategies.
  • Focus on differentiating fungal-related dis-immunity in severe asthma.

Main Results:

  • Shared pathobiological backgrounds and clinical similarities between severe asthma and ABPA can mislead diagnosis.
  • Biomarkers, while specific, may not always provide clear differential diagnoses.
  • SAFS represents a significant challenge in phenotyping severe asthma patients.

Conclusions:

  • Accurate recognition and pheno-endotyping of severe asthma, ABPA, and SAFS are essential for effective management.
  • Further research into pathobiological drivers and innovative targeted treatments is warranted.
  • Improved diagnostic strategies are needed to prevent disease progression and achieve remission.

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
593
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
148
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.1K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
583